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Objective:  In short-term feeding trials, replacement of other macronutrients with 
monounsaturated fatty acid reduces blood pressure. However, observational studies have not 
clearly demonstrated a relationship between monounsaturated fatty acid intake and blood 
pressure. We report associations of monounsaturated fatty acid intake of individuals with blood 
pressure in a cross-sectional study. 
Methods:  The International Study of Macro/Micronutrients and Blood Pressure is a cross-
sectional epidemiologic study of 4,680 men and women ages 40-59 from 17 population samples 
in China, Japan, United Kingdom, and United States.  Nutrient intake data were based on four in-
depth multi-pass 24-hour dietary recalls/person and two timed 24-hour urine collections/person.  
Blood pressure was measured eight times at four visits.   
Results:  Mean monounsaturated fatty acid intake ranged from 8.1 %kcal (China) to 12.2%kcal 
(United States).  With sequential models to control for possible confounders (dietary, other), 
linear regression analyses showed significant inverse relationship of total monounsaturated fatty 
acid intake with diastolic blood pressure for all participants; for 2,238 “non-intervened” 
individuals, the relationship was stronger.  Estimated diastolic blood pressure differences with 2-
SD higher monounsaturated fatty acids (5.35 %kcal) were -0.82 mm Hg (P<0.05) for all 
participants and -1.70 mm Hg (P<0.01) for non-intervened individuals.  Inverse associations of 
dietary total oleic acid (main monounsaturated) with blood pressure in non-intervened 
individuals were not significant, but those of oleic acid from vegetable sources were stronger and 
significant (P<0.05). 
Conclusions:  Dietary monounsaturated fatty acid intake, especially oleic acid from vegetable 





The associations of monounsaturated fatty acid intake of individuals with blood pressure was 
investigated in a cross-sectional epidemiologic study of 4,680 men and women ages 40-59 from 
17 population samples in China, Japan, United Kingdom, and United States.  Linear regression 
analyses showed significant inverse relationship of total monounsaturated fatty acid intake with 
diastolic blood pressure.  Inverse associations of dietary total oleic acid from vegetable sources 
with blood pressure in non-intervened individuals were stronger and significant.  Dietary 
monounsaturated fatty acid intake, especially oleic acid from vegetable sources, may contribute 
to prevention and control of adverse blood pressure levels in general populations. 
 
Key words:  Blood pressure; nutrition; monounsaturated fatty acids; oleic acid; population study 
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A Mediterranean diet has been reported to reduce cardiovascular disease risk [1].  A major 
characteristic of a Mediterranean diet is a high proportion of energy from monounsaturated fatty 
acids (MFA), mainly from olive oil.  Dietary intake of MFA has been hypothesized to have a 
favorable effect on blood pressure (BP).  Data from short term feeding trials have documented 
that MFA replacement of saturated fatty acids (SFA), polyunsaturated fatty acids (PFA), or 
carbohydrate lowered BP [2-5].  However, findings from observational studies, cross-sectional 
and longitudinal, have been inconsistent [6-12].  Thus, effects of dietary MFA on BP in the 
general population merit further study.  Possible reasons for inconsistencies across studies 
include limitations in methods of dietary assessment, e.g., a single 24-h dietary recall, or use of 
food frequency questionnaires, with consequent limited ability to classify dietary intake of 
individuals accurately; BP measurements insufficiently standardized; and small sample sizes 
with resultant low statistical power.   
 
The population-based International Study of Macro/Micronutrients and Blood Pressure 
(INTERMAP) was designed to address these problems [13-25].  Its basic premise is that multiple 
nutrients have small independent influences on BP of individuals that in combination summate 
as sizable effects.  To detect the impact of single nutrients or foods on BP of individuals, it is 
essential to collect standardized, high-quality data on large samples of diverse populations.  
Accordingly, INTERMAP surveyed in-depth 4,680 men and women, ages 40-59, from 17 
population samples in Japan, Peoples Republic of China, United Kingdom, and United States.  
INTERMAP investigators hypothesized that intakes of total MFA and its main constituent oleic 
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Population Samples, Field Methods (1996-1999) 
INTERMAP included 4,680 men and women ages 40-59 years from population samples in Japan 
(four samples), People’s Republic of China (PRC, three), United Kingdom (UK, two), and 
United States (USA, eight) [13].  Participants were selected randomly from population lists, 
stratified by age/gender.  Staff were trained, standardized, and certified for BP measurement by 
international/national senior colleagues based on a common protocol [13].  Each participant 
attended four visits, visits 1 and 2 on consecutive days, visits 3 and 4 on consecutive days on 
average 3 weeks later.  For BP measurement, each participant -- having emptied his/her bladder -
- was seated comfortably for five minutes, feet flat on the floor, in a quiet room, with no physical 
activity in the preceding half hour.  Korotkoff sounds I and V were criteria for systolic BP (SBP) 
and diastolic BP (DBP).  BP was measured twice at each visit with a random zero 
sphygmomanometer; BP at each visit was the average of the two readings.  Measurements of 
height and weight, and questionnaire data on daily alcohol consumption over the previous seven 
days were obtained at two visits (14 days total).  Dietary data were collected at each visit by a 
trained certified interviewer with use of the in-depth multi-pass 24-hr recall method [14].  All 
foods and drinks consumed in the previous 24 hours, including dietary supplements, were 
recorded.  Questionnaire data were obtained on demographic, biomedical, and other possible 
confounders.  Quality control throughout the field surveys was on-going and extensive at the 
international, national, and local levels [13, 14].  
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Each participant provided two 24-hour urine collections, start and end timed at the research 
center (visits 1-2 and 3-4); measurements included urinary volume, sodium, potassium, 
creatinine [13]; 8% of urine samples were split locally and sent blind to the Central Laboratory to 
estimate technical error. 
 
Individuals were excluded if they did not attend all four visits; diet data were considered 
unreliable; energy intake from any 24-hour dietary recall was below 500 kcal/day or greater than 
5,000 kcal/day for women, 8,000 kcal/day for men; two urine collections were not available; data 
on other variables were incomplete or indicated protocol violation (total exclusions: 215 people).   
 
The study received institutional ethics committee approval for each site; all participants gave 
written informed consent.   
 
Statistical Methods 
Food data of individuals were converted into nutrients (83 nutrients) with use of enhanced 
country-specific food tables, standardized across countries by the Nutrition Coordinating Center, 
University of Minnesota [14, 15].  For nutrients supplying energy, intake was calculated as 
percent total energy (%kcal); for others, as intake/1,000 kcal; nutrients were calculated also as 
amounts/24 hours.  Food data were used to assess main food groups supplying total MFA and its 
main component oleic acid.  Urinary values/24 hours were calculated as products of urinary 
concentrations and timed volumes standardized to 24 hours.  Measurements/person were 
averaged, for BP and nutrient variables, across the four visits and for urinary excretions across 
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the two collections.  For descriptive statistics, means and standard deviations, numbers and 
percentages were calculated by country and study-wide.   
 
Associations among nutritional variables were explored by partial correlation, adjusted for 
sample, age, gender; pooled across countries, weighted by sample size.  Multiple linear 
regression analyses were used to examine relationships of dietary MFA and oleic acid (%kcal) of 
individuals to their SBP and DBP.  These analyses were done for two cohorts: all 4,680 
participants and 2,238 “non-intervened” persons not being on a special diet, not consuming 
nutritional supplements, not diagnosed with cardiovascular disease/diabetes, and not taking 
medication for high BP, cardiovascular disease or diabetes; i.e., exclusion of people whose data 
might bias the dietary MFA-BP relationship.  Adjustment for confounders was done 
sequentially: for sample, age, gender, body mass index (BMI), moderate/heavy physical activity 
(hours/day), smoking status (current smoker or not), family history of hypertension, reported 
special diet, dietary supplement intake, history of cardiovascular disease, or diabetes (model A); 
plus 24-hour urinary sodium, potassium, and 7-day alcohol intake (model B); plus dietary 
cholesterol, total SFA, calcium (model C).  Models D1–D3 were adjusted for model C variables 
plus each stipulated nutrient; i.e., dietary fiber (model D1), dietary phosphorus (model D2), and 
vegetable protein (model D3).  Corresponding analyses were done for dietary total oleic acid, 
oleic acid from animal sources, oleic acid from vegetable sources (%kcal) instead of dietary 
MFA.  For these analyses, model E involved adjustment for non-heme iron [20] and glutamic 
acid [21] in addition to model D3 variables. 
 
Regression models were fit separately by country and coefficients pooled across countries, 
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weighted by inverse of variance, to estimate overall associations; cross-country heterogeneity 
was tested; interactions were assessed for age and gender.  Regression coefficients were 
expressed as mm Hg for two standard deviation (SD) difference in dietary MFA or oleic acid, 
from pooled within-country standard deviations weighted by sample size.  Adjusted mean BPs 
by quartiles of dietary MFA were also calculated and plotted in a figure. 
 




Average SBP ranged from 117.2 (Japan) to 121.3 mm Hg (PRC); average DBP, from 73.2 (PRC) 
to 77.3 (UK) mm Hg (Online Table 1).  Mean BMI and energy intake were lower for Japanese 
and PRC participants, highest for American participants.  Mean total MFA intake from foods 
was highest in USA (31.9 g/day, 12.2 %kcal) and lowest in PRC (18.5 g/day, 8.1 %kcal).  Mean 
oleic acid intake was highest in USA (29.8 g/day, 11.6 %kcal) and lowest in PRC (15.4 g/day, 
6.7 %kcal); oleic acid was about 91% of total MFA (range across countries: 83%, PRC to 95%, 
USA).  Main food groups supplying MFA were, first, fats/oils/margarines (51%, PRC; 32%, 
USA; 31%, UK; 26%, Japan), and, second, meat (26%, USA; 21%, UK; 20%, PRC; 20%, Japan) 
(Online Table 2). MFA was also consumed in milk/cheese, cakes/puddings/cookies/other sweet 
snacks, fish, condiments/seasonings, and pasta/rice/noodles.  
 
Partial Correlation Data 
High direct correlations prevailed for dietary MFA (%kcal) with SFA (partial r=0.73), PFA 
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(0.52), n-6 PFA (0.51), dietary cholesterol (0.37); inverse correlations with vegetable protein  
(-0.33), fiber (-0.29), and magnesium (-0.28) (Online Table 3).  MFA correlations were small 
with calcium, urinary sodium, potassium, 7-day alcohol (partial r values -0.09 to +0.09).  All the 
foregoing correlations prevailed also for total oleic acid; oleic acid from animal sources 
correlated directly with total SFA (partial r=0.73); oleic acid from vegetable sources correlated 
directly with total PFA (0.63) and n-6 PFA (0.63). 
 
Relation of Dietary MFA to Blood Pressure 
All 4,680 participants:  In models A and B, dietary MFA was not related to SBP and DBP (Table 
1).    In model C with further adjustment also for dietary cholesterol, total SFA, and calcium, 
dietary MFA was significantly and inversely related to DBP; results were similar with additional 
adjustment for fiber, phosphorus, or vegetable protein (models D1-3).  With two SD higher MFA 
(5.35 %kcal = about 12.8 grams/day), estimated difference in average DBP was approximately  
-0.8 mm Hg.  Interactions with age or gender were not statistically significant in most models.  
While all tests for cross-country heterogeneity were non-significant for DBP, the inverse MFA-
BP relation was largest for Chinese participants, e.g., model D3, estimated DBP difference -2.70 
mm Hg with 2 SD higher MFA (Z-score -2.35; P<0.05) (Online Table 4).  Corresponding 
analyses with control for urinary Na/creatinine and K/creatinine (instead of 24-hour Na and K 
excretion) yielded similar findings (data not tabulated).  SBP was not associated with MFA in 
any models. 
 
Multivariate-adjusted mean values of DBP by quartiles of dietary MFA showed a linear inverse 
relation (P for trend = 0.036) (Figure).  Adjusted mean DBP was 73.7 mm Hg in the 1st quartile 
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and 71.1 mm Hg in the 4th quartile. 
 
“Non-intervened” subcohort (n = 2,238):  In this subcohort, the percentage of persons with 
untreated high BP was: 11.8% (men) and 5.6% (women).  Dietary MFA was inversely related to 
SBP and DBP, significantly to DBP (Table 1).  Estimated SBP and DBP differences were 
consistently greater than for all participants, e.g., model D3, SBP difference -1.29 mm Hg (Z-
score -1.39; P=0.16), DBP difference -1.70 mm Hg (Z-score -2.65; P<0.01) with 2 SD higher 
MFA.  Interactions with age or gender were not significant in most models.  While tests for 
cross-country heterogeneity were non-significant, BP differences were larger for Chinese 
participants, SBP -2.31 mm Hg, DBP -3.17 mm Hg, and for UK participants, SBP -4.12 mm Hg, 
DBP -2.15 mm Hg (model D3) (Online Table 4).  Analyses with control for urinary 
Na/creatinine and K/creatinine yielded similar findings, e.g., model D3, SBP difference -1.22 
mm Hg (Z-score -1.32; P=0.18) and DBP difference -1.68 mm Hg (Z-score -2.63; P<0.01) with 
2 SD higher MFA (data not tabulated). 
 
Relation of Dietary Oleic Acid to Blood Pressure 
Total dietary oleic acid:  For all 4,680 participants, dietary total oleic acid was non-significantly 
inversely related to DBP in multivariate-adjusted models (Table 2).  For the non-intervened 
subcohort, dietary total oleic acid tended to relate inversely non-significantly to SBP and DBP; 
estimated SBP and DBP differences with 2 SD higher intake were larger than for all participants. 
 
Dietary oleic acid from vegetable sources:  Dietary oleic acid from vegetable sources was related 
inversely with SBP and DBP in all participants (Table 2) -- SBP difference -0.70 mm Hg, DBP 
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difference -0.57 mm Hg (Z-score -2.01; P<0.05) with 2 SD higher oleic acid from vegetable 
sources (4.12 %kcal = about 9.8 grams/day) (model E).  The relationships were stronger for non-
intervened participants; estimated SBP and DBP differences with 2 SD higher intake were -1.26 
mm Hg (Z-score -1.97; P<0.05) and -1.02 mm Hg (Z-score -2.32; P<0.05) (model E).   
 
Dietary oleic acid from animal sources:  In contract to the inverse relationship of dietary oleic 
acid from vegetable sources with BP, dietary oleic acid from animal sources was positively 
associated with SBP and DBP for all participants and non-intervened participants (Table 2), with 
relationships weaker for non-intervened participants, non-significant in models D3 and E for 




Main findings of this population-based study are independent inverse relations of dietary MFA 
and oleic acid (principal MFA) to DBP, estimated effect size -0.8 to -1.7 mm Hg DBP with 2 SD 
higher MFA intake (approximately 13 grams/day).  These results are consistent with those from 
the DASH and OMNIHEART feeding trials and other studies [2-5, 26, 27].  In INTERMAP, 
relations to BP of oleic acid from vegetable sources were stronger than those of total oleic acid 
intake.  Also, a direct (not inverse) association with BP was observed for oleic acid from animal 
sources.   
 
In INTERMAP, over 90% of dietary total MFA intake was oleic acid (cis C18:1 n-9) (range in 
countries from 83%, PRC to 95%, USA); 58% of oleic acid was from vegetable sources.  Some 
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vegetable oils contain much MFA (over 70% in olive oil and over 60% in canola oil), other 
vegetable oils differ (e.g., less than 30% in corn oil and sunflower oil).  MFA makes up over 
40% of animal fats (e.g., lard, chicken fat, beef tallow) [28].  Therefore, relation of MFA or oleic 
acid to BP in free-living people in observational studies differs potentially from that in 
intervention studies where MFA is usually from supplemental vegetable oil, mainly olive oil. 
 
In the present study, DBP was significantly and SBP tended to be related inversely to total MFA 
intake, especially in non-intervened participants who are presumably less likely to have changed 
their dietary habit intentionally.  Previous observational studies, cross-sectional and longitudinal, 
showed no or direct association between MFA intake and BP in US populations [8, 9] and 
inverse association in Mediterranean countries where olive oil consumption is higher [10-12].  
Our findings from East Asian and Western population samples lend support to the concept of a 
favorable effect of MFA intake on BP.   
 
In our study, oleic acid from vegetable -- but not animal -- sources was inversely related to SBP 
and DBP.  Data from previous observational [10-12] and intervention studies [2-5] suggest a BP-
lowering effect of MFA from vegetable oils, mostly olive oil.  Other components in oleic acid-
rich vegetable oils (e.g., polyphenols and vitamins with antioxidant effect) may be contributing 
to lower BP [29, 30]. 
 
Reasons are unclear for the unexpected direct relationship to BP of oleic acid from animal 
sources.  It was significant -- especially for SBP -- with control for multiple possible confounders 
systemically/routinely considered by INTERMAP, and with further control for others as well 
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(correlates of oleic acid from animal products) in total participants.  However, the relationship 
was no longer significant after adjustment for vegetable protein in non-intervened participants.  
Oleic acid in these analyses includes both cis- and trans-isomers, e.g., elaidic acid (C18:1 trans 
n-9) and vaccenic acid (C18:1 trans n-7); the latter is the most common trans isomer in beef and 
dairy products.  Possible residual confounding by such factors as trans-MFA could not be 
controlled in our study. 
 
Limitations of the INTERMAP findings include the cross-sectional study design.  However, our 
data are the only available extensive high-quality population-based data on dietary MFA and BP.  
Another concern is underestimation of effect size due to limited reliability in measurement of 
nutrients (regression dilution bias), despite multiple standardized state-of-the-art measurements.  
Third, because of high-order collinearity (e.g., MFA with SFA or PFA), we have limited ability 
to control for the BP effects of these nutrients.  Fourth, four current 24-hr dietary recalls may not 
for some persons yield accurate data on individual’s long-term dietary intake of MFA. 
 
The apparently small effect of MFA on BP, anticipated by INTERMAP [13], needs to be kept in 
perspective: First, with multiple nutrients having “small” independent influences, the combined 
effect is potentially quite sizable, i.e., improved nutrition is capable of preventing or lowering 
unfavorable BP levels for most people, as the INTERMAP, as well as DASH and OMNIHEART 
feeding trial, results indicate [5, 26].  Second, long-term BP effects of habitual eating patterns, 
from early life into middle-age, may be greater, as data on salt intake and BP indicate [31].  
Third, lowering of population average SBP by “small” amounts (e.g., 2 mm Hg) is estimated to 
reduce mortality rates 6% for stroke, 4% for CHD [31].  Fourth, INTERMAP data also indicate 
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low-order independent favorable influences on BP of food n-3 and n-6 PFA, vegetable protein, 
calcium, phosphorus, magnesium, non-heme iron, potassium, and other nutrients on BP, as well 
as lower sodium intake, avoidance of heavy alcohol consumption, and prevention and control of 
overweight/obesity -- adding up to estimated sizable combined effect for general populations 
[16-25, 32]. 
 
In conclusion, there was an inverse relationship of dietary MFA intake to BP with control for 
multiple possible confounders.  This finding was stronger for dietary oleic acid intake from 
vegetable sources and in persons not experiencing dietary/medical intervention.  Dietary 
monounsaturated fatty acid intake, especially oleic acid from vegetable sources, may contribute 
to prevention and control of adverse blood pressure levels in general populations.  These results 
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Table 1. Estimated mean difference in blood pressure (mm Hg) associated with total monounsaturated fatty acids (%kcal) higher by 
two standard deviations a (sequential regression models), INTERMAP. 
 Systolic blood pressure Diastolic blood pressure 
Model Variables added sequentially 
b Difference 
(mm Hg) Z-score 
Difference 
(mm Hg) Z-score 
All participants (n=4,680) 
A  0.28 c 0.71 -0.11 -0.39 
B Urinary Na, urinary K, alcohol 0.32 d 0.78 -0.08 -0.28 
C Cholesterol, total SFA, calcium 0.05 0.08 -0.84 -2.02 e 
D1 Fiber 0.09 0.15 -0.83 -2.00 e 
D2 Phosphorus -0.005 -0.01 -0.84 -2.02 e 
D3 Vegetable protein 0.12 0.20 -0.82 -1.97 e 
Non-intervened participants (n = 2,238) 
C Cholesterol, total SFA, calcium -1.22 -1.33 -1.54 -2.43 e 
D3 Vegetable protein -1.29 -1.39 -1.70 -2.65 f 
 
Na, sodium; K, potassium; SFA, saturated fatty acids. 
a Two standard deviation difference is 5.35 %kcal for monounsaturated fatty acids. 
b Model A includes sample, age, gender, body mass index, physical activity, smoking status, family history of hypertension, special 
diet, supplement intake, and CVD-DM diagnosis (the latter 3 variables were not included in models for non-intervened participants). 
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From model B to C, variables listed are added to each prior model. Models D1–D3 are adjusted for model C variables plus each 
stipulated nutrient. 
Special diet: Weight loss, weight gain, vegetarian, salt reduced, diabetic, fat modified, or any other special diet. CVD-DM: History of 
heart attack, other heart disease, stroke, or diabetes. Supplement intake: Taking any dietary supplement at time of the study. 
Test for cross-country heterogeneity significant at   c  P<0.01, d  P<0.05. 





Table 2. Estimated mean difference in blood pressure (mm Hg) associated with oleic acid (%kcal) higher by two standard deviations a 
(sequential regression models), INTERMAP. 
 Systolic blood pressure Diastolic blood pressure 
Model Variables added sequentially 
b Difference 
(mm Hg) Z-score 
Difference 
(mm Hg) Z-score 
Total oleic acid (%kcal) 
All participants (n=4,680) 
C Cholesterol, total SFA, calcium 0.07 0.12 -0.57 -1.35 
D3 Vegetable protein 0.21 0.34 -0.50 -1.19 
E Non-heme iron, glutamic acid 0.20 0.32 -0.54 -1.27 
Non-intervened participants (n = 2,238) 
C Cholesterol, total SFA, calcium -1.02 -1.08 -0.99 -1.49 
D3 Vegetable protein -1.01 -1.07 -1.08 -1.61 
E Non-heme iron, glutamic acid -1.07 -1.11 -1.11 -1.64 
Oleic acid from vegetable sources (%kcal) 
All participants (n=4,680) 
C Cholesterol, total SFA, calcium -0.84 -2.06 c -0.65 -2.33 c 
D3 Vegetable protein -0.74 -1.79 -0.59 -2.10 c 
E Non-heme iron, glutamic acid -0.70 -1.69 -0.57 -2.01 c 
Non-intervened participants (n = 2,238) 
C Cholesterol, total SFA, calcium -1.28 -2.05 c -1.01 -2.36 c 
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D3 Vegetable protein -1.24 -1.97 c -1.01 -2.33 c 
E Non-heme iron, glutamic acid -1.26 -1.97 c -1.02 -2.32 c 
Oleic acid from animal sources (%kcal) 
All participants (n=4,680) 
C Cholesterol, total SFA, calcium 2.47 3.73 d 0.94 2.07 c 
D3 Vegetable protein 2.37 3.58 d 0.86 1.91 
E Non-heme iron, glutamic acid 2.43 3.50 d 0.80 1.68 
Non-intervened participants (n = 2,238) 
C Cholesterol, total SFA, calcium 1.80 1.88 1.22 1.86 
D3 Vegetable protein 1.71 1.78 1.09 1.67 
E Non-heme iron, glutamic acid 1.79 1.77 1.14 1.67 
 
Na, sodium; K, potassium; SFA, saturated fatty acids. 
a Two standard deviation differences are 5.10 %kcal for total oleic acid, 4.12 %kcal for oleic acid from vegetable sources, and 3.86 
%kcal for oleic acid from animal sources. 
b See Table 1 for variables adjusted in each model.  Models E are controlled for model D3 variables plus non-heme iron and glutamic 
acid. 
c P<0.05, d P<0.01. 





Figure.  Adjusted mean values of diastolic blood pressure by quartiles of total monounsaturated 
fatty acid intake (%kcal) in all participants (n=4,680).  Mean values were adjusted for variables 
in model D3 (see Table 1 for variables).  Cut-off values of the quartiles are 8.31%kcal, 
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 Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Age (years) 49.4 (5.3) 49.0 (5.8) 49.1 (5.6) 49.1 (5.4) 49.2 (5.5) 
Systolic BP (mm Hg) 117.2 (13.8) 121.3 (17.4) 120.4 (14.6) 118.6 (13.9) 118.9 (14.7) 
Diastolic BP (mm Hg) 73.6 (10.3) 73.2 (10.2) 77.3 (9.9) 73.4 (9.7) 73.8 (10.0) 
Energy (kcal/24hr) 2038.6 (449.0) 2035.8 (576.8) 2167.8 (631.8) 2244.2 (698.7) 2148.4 (624.5) 
Total fat (%kcal) 24.9 (5.0) 20.0 (6.1) 32.8 (6.5) 32.9 (6.9) 28.6 (8.2) 
Total MFA (%kcal) 9.0 (2.2) 8.1 (2.8) 11.0 (2.5) 12.2 (2.9) 10.5 (3.2) 
Oleic acid (%kcal) 8.0 (2.0) 6.7 (2.8) 10.0 (2.3) 11.6 (2.8) 9.6 (3.2) 
Oleic acid from vegetable 
sources (%kcal) 
4.7 (1.6) 4.0 (1.6) 5.8 (2.2) 6.7 (2.3) 5.6 (2.3) 
Oleic acid from animal sources 
(%kcal) 
3.3 (1.2) 2.7 (1.9) 4.2 (1.9) 4.9 (2.1) 4.0 (2.1) 
Total SFA (%kcal) 6.6 (1.8) 5.0 (2.0) 12.1 (3.3) 10.7 (2.8) 8.8 (3.6) 
Total PFA (%kcal) 6.4 (1.5) 5.8 (2.2) 6.2 (1.9) 7.0 (2.2) 6.5 (2.1) 
continued on next page 
 Online Table 1 continued, page 2 
Total fat (g/day) 56.8 (16.6) 45.9 (20.4) 81.0 (31.7) 84.4 (33.9) 70.4 (32.3) 
Total MFA (g/day) 20.6 (6.7) 18.5 (8.6) 27.3 (11.0) 31.9 (13.5) 26.2 (12.5) 
Oleic acid (g/day) 18.3 (6.2) 15.4 (8.2) 24.8 (10.0) 29.8 (12.6) 23.8 (12.0) 
Oleic acid from vegetable souces 
(g/day) 
10.7 (4.3) 9.3 (5.3) 14.4 (7.1) 17.3 (8.5) 13.9 (7.8) 
Oleic acid from animal souces 
(g/day) 
7.6 (3.4) 6.1 (5.6) 10.3 (6.2) 12.5 (7.1) 9.9 (6.6) 
Total TFA (%kcal) 0.44 (0.30) 0.18 (0.34) 1.36 (0.61) 1.94 (0.80) 1.20 (0.98) 
PFA/SFA ratio 1.09 (0.31) 1.39 (0.57) 0.60 (0.26) 0.74 (0.29) 0.93 (0.45) 
Cholesterol (mg/1,000 kcal) 197.2 (66.9) 89.0 (85.9) 120.4 (48.3) 131.4 (58.8) 138.7 (75.0) 
Animal protein (%kcal) 8.9 (2.4) 2.5 (2.4) 9.8 (3.3) 10.2 (3.2) 8.4 (4.1) 
Vegetable protein (%kcal) 7.1 (1.1) 9.9 (1.3) 6.1 (1.4) 5.2 (1.6) 6.6 (2.2) 
Glutamic acid (% total protein) 17.8 (1.4) 24.1 (4.4) 20.5 (1.6) 19.8 (1.7) 20.1 (3.1) 
Calcium (mg/1,000 kcal) 305.6 (108.7) 149.3 (56.2) 445.4 (118.7) 363.0 (142.0) 319.4 (149.1) 
Magnesium (mg/1,000 kcal) 134.4 (25.2) 154.6 (46.6) 153.3 (35.0) 148.1 (40.0) 146.5 (38.5) 
Phosphorus (mg/1,000 kcal) 562.6 (94.4) 438.9 (113.2) 661.6 (126.1) 591.0 (124.6) 564.4 (132.7) 
continued on next page 
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Non-heme iron (mg/1,000 kcal) 4.8 (1.1) 7.5 (1.6) 5.8 (1.5) 7.3 (2.7) 6.6 (2.3) 
Fiber (g/1,000 kcal) 7.9 (2.3) 14.2 (3.8) 12.2 (3.8) 9.0 (3.4) 10.0 (4.0) 
Vitamin E (mg/1,000 kcal) 4.9 (1.4) 5.3 (1.6) 4.5 (1.6) 4.5 (1.8) 4.7 (1.7) 
7-Day alcohol a (g/24hr) 17.0 (22.6) 8.6 (21.4) 14.7 (19.2) 6.9 (13.7) 10.5 (18.8) 
7-Day alcohol among drinkers a 
(g/24hr) 
18.8 (23.0) 18.9 (28.4) 16.6 (19.6) 9.9 (15.4) 14.5 (20.7) 
Urinary sodium (mmol/24hr) 198.3 (56.2) 227.5 (100.3) 145.2 (49.1) 162.6 (59.4) 181.1 (72.4) 
Urinary potassium (mmol/24hr) 48.9 (13.6) 38.3 (12.7) 68.2 (20.1) 57.7 (20.9) 53.2 (20.0) 
Height (m) 1.61 (0.09) 1.59 (0.08) 1.69 (0.09) 1.68 (0.10) 1.65 (0.10) 
Weight (kg) 61.2 (10.2) 58.9 (10.0) 78.2 (15.3) 82.3 (19.6) 72.5 (19.0) 
Body Mass Index (kg/m2) 23.4 (2.9) 23.1 (3.4) 27.5 (4.6) 28.9 (5.9) 26.4 (5.5) 
 n (%) n (%) N (%) n (%) n (%) 
Family history of hypertension 
in any first degree relative 
                              -Yes 
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Current alcohol drinkers 1,039 (90.7) 382 (45.5) 444 (88.6) 1,533 (69.8) 3,398 (72.6) 
Current cigarette smokers  346 (30.2) 305 (36.4) 87 (17.4) 369 (16.8) 1,107 (23.7) 
Special diet: weight loss, weight 
gain, vegetarian, salt reduced, 
diabetic, fat modified, or other  
76 (6.6) 45 (5.4) 106 (21.2) 401 (18.3) 628 (13.4) 
Taking dietary supplement 243 (21.2) 34 (4.1) 191 (38.1) 1,136 (51.8) 1,604 (34.3) 
High blood pressure  b 153 (13.4) 145 (17.3) 116 (23.2) 595 (27.1) 1,009 (21.6) 
History of heart attack, other 
heart disease, stroke, or diabetes 
131 (11.4) 59 (7.0) 54 (10.8) 343 (15.6) 587 (12.5) 
Taking prescribed drug 
treatment for high BP, CVD c, 
diabetes, or affecting 
cardiovascular system 
124 (10.8) 86 (10.3) 98 (19.6) 644 (29.3) 952 (20.3) 
 
BP, blood pressure; PFA, polyunsaturated fatty acids; SFA, saturated fatty acids; MFA, monounsaturated fatty acids; TFA, trans fatty 
acids; CVD, cardiovascular diseases. 
a Average daily alcohol intake, from two histories per person of daily alcohol intake during the preceding 7 days. 
b Systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg or reporting use of medication for high BP 
c Includes lipid-lowering drugs 
   
 Online Table 2. Foods contributing >1% of total monounsaturated fatty acid intake. 
Japan (n=1145) P. R. China (n=839) UK (n=501) USA (n=2195) 
Food source g/day % Food source g/day % Food source g/day % Food source g/day % 
Fats, oils & 
margarines 5.3 25.5
Fats, oils & 
margarines 9.4 50.5
Fats, oils & 
margarines 8.4 30.7
Fats, oils & 
margarines 10.3 32.3 
Meats 4.1 19.8 Meats 3.7 20.0 Meats 5.8 21.1 Meats 8.2 25.8 
Fish 1.9 9.2




cookies & other 
sweet snacks 4.1 15.1 Milk & cheese 2.4 7.5 
Condiments & 
seasonings 1.8 8.5 Eggs 0.9 5.0 Milk & cheese 2.4 8.7
Condiments & 
seasonings 2.0 6.2 
Eggs 1.7 8.1 Grains & flour 0.9 4.9 Savoury snacks 1.0 3.8
Cakes, 
puddings, 
cookies & other 
sweet snacks 1.9 5.9 
Milk & cheese 1.2 5.6 Nuts & seeds 0.9 4.8
Bread, rolls, 
biscuits 1.0 3.6 Nuts & seeds 1.8 5.5 
Cakes, 
puddings, 
cookies & other 
sweet snacks 1.1 5.3
Bread, rolls, 
biscuits 0.6 3.0 Eggs 0.7 2.5
Bread, rolls, 





cookies & other 
sweet snacks 0.3 1.5
Soup, gravy & 
sauces 0.7 2.4 Eggs 1.1 3.3 
Pasta, rice & 
noodles 0.7 3.6
Vegetarian meat 
substitutes 0.3 1.5 Nuts & seeds 0.6 2.3
Ice-cream & 
frozen treats 0.6 1.9 
Bread, rolls, 
biscuits 0.6 2.9 Fish 0.2 1.1
Condiments & 
seasonings 0.5 1.7 Savoury snacks 0.6 1.9 
Nuts & seeds 0.6 2.8  Fish 0.4 1.5
Other dairy 
products 0.4 1.1 
Other dairy 
products 0.3 1.5  
Other dairy 
products 0.4 1.4   
   
Vegetables & 
beans 0.4 1.3   
    Cereals 0.3 1.1   
 
  
 Online Table 3. Partial correlation coefficients a of monounsaturated fatty acids, oleic acid with other variables. 
Variable 
Total MFA Oleic acid 
Oleic acid from 
vegetable sources 
Oleic acid from 
animal sources 
Total MFA 1 0.98 0.64 0.60 
Oleic acid 0.98 1 0.68 0.58 
Oleic acid from vegetable sources 0.64 0.68 1 -0.20 
Oleic acid from animal sources 0.60 0.58 -0.20 1 
Total energy 0.16 0.15 0.11 0.08 
Total fat 0.94 0.93 0.58 0.60 
Total SFA 0.73 0.72 0.22 0.73 
Total PFA 0.52 0.54 0.63 0.03 
Total n-3 PFA 0.34 0.27 0.30 0.04 
Total n-6 PFA 0.51 0.54 0.63 0.02 
PFA/SFA ratio -0.18 -0.17 0.26 -0.52 
Keys score 0.55 0.53 -0.04 0.76 
Dietary cholesterol 0.37 0.35 -0.04 0.52 
Total TFA 0.45 0.46 0.42 0.15 
Animal protein 0.19 0.17 -0.18 0.42 
Vegetable protein -0.33 -0.31 -0.01 -0.40 
Glutamic acid -0.03 -0.04 -0.14 0.13 
Calcium -0.09 -0.10 -0.10 -0.02 
Magnesium -0.28 -0.27 -0.09 -0.25 
Phosphorus -0.13 -0.14 -0.19 0.04 
Non-heme iron -0.15 -0.14 -0.03 -0.14 
  
 
MFA, monounsaturated fatty acids; SFA, saturated fatty acids; PFA, polyunsaturated fatty acids; TFA, trans fatty acids; Na, sodium; 
K, potassium; BMI, body mass index. 
Variables are %kcal (total MFA, oleic acid,  total fat, total SFA, total PFA, n-6 PFA, n-3 PFA, TFA, animal protein, vegetable protein, 
glutamic acid), kcal (energy), mg/1,000 kcal (cholesterol, calcium, magnesium, phosphorus, vitamin E), g/1,000 kcal (fiber), g/24-h 
(7-day alcohol), mmol/24-h (urinary Na, urinary K), m (height), kg (weight), kg/m2 (BMI). 




Fiber -0.29 -0.27 -0.06 -0.29
Vitamin E 0.26 0.26 0.43 -0.12 
7-day alcohol -0.09 -0.09 -0.11 0.00 
Urinary Na 0.09 0.09 0.01 0.11 
Urinary K -0.08 -0.08 -0.03 -0.06 
Urinary Na/K ratio 0.13 0.13 0.02 0.14 
Height 0.06 0.05 0.05 0.02 
Weight 0.13 0.12 0.02 0.14 
BMI 0.11 0.10 0.00 0.14 
 Online Table 4. Country specific estimated mean difference in blood pressure (mm Hg) associated with total monounsaturated fatty 
acids (%kcal) higher by two standard deviations a (model D3 b), INTERMAP.  
 
 
a Two standard deviation difference is 5.35 %kcal for monounsaturated fatty acids. 
b See Table 1 for variables adjusted in model D3.  
c P<0.05 
 
  Systolic blood pressure  Diastolic blood pressure 
Country n Difference (mm Hg) Z-score  
Difference 
(mm Hg) Z-score 
All participants (n=4,680) 
Japan 1145 -0.34 -0.23  -0.38 -0.35 
PRC 839 -1.18 -0.60  -2.70 -2.35 c 
UK 501 0.86 0.47  0.73 0.58 
USA 2195 0.32 0.42  -0.80 -1.49 
Non-intervened participants (n = 2,238) 
Japan 695 -1.16 -0.66  -0.25 -0.19 
PRC 691 -2.31 -1.11  -3.17 -2.55 c 
UK 204 -4.12 -1.40  -2.15 -1.13 
USA 648 -0.23 -0.16  -1.43 -1.39 
